Halofantrine in the treatment of falciparum malaria

Indian J Malariol. 1995 Mar;32(1):1-5.

Abstract

50 patients (45 males + 5 females) suffering from acute uncomplicated attack of Plasmodium falciparum (Pf) malaria were treated with 1500 mg of halofantrine divided in three doses of 500 mg each given at an interval of 6 h. Results showed there were no primary treatment failures. Average Parasite Clearance Time (av. PCT) was 51.12 h and average Fever Clearance Time (av. FCT) was 31.25 h. Adverse Drug Reactions (ADR) were mild and self limiting. We conclude that halofantrine is a quite safe and effective new antimalarial agent in the treatment of Pf malaria cases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Antimalarials / adverse effects
  • Antimalarials / therapeutic use*
  • Female
  • Humans
  • Malaria, Falciparum / drug therapy*
  • Male
  • Middle Aged
  • Phenanthrenes / adverse effects
  • Phenanthrenes / therapeutic use*

Substances

  • Antimalarials
  • Phenanthrenes
  • halofantrine